511 related articles for article (PubMed ID: 11880861)
1. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
Kariyawasam SH; Zaw F; Handley SL
Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
[TBL] [Abstract][Full Text] [Related]
2. Cortisol awakening response in healthy children and children with ADHD: impact of comorbid disorders and psychosocial risk factors.
Freitag CM; Hänig S; Palmason H; Meyer J; Wüst S; Seitz C
Psychoneuroendocrinology; 2009 Aug; 34(7):1019-28. PubMed ID: 19278790
[TBL] [Abstract][Full Text] [Related]
3. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.
Goez H; Back-Bennet O; Zelnik N
J Child Neurol; 2007 May; 22(5):538-42. PubMed ID: 17690058
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
Barnett R; Maruff P; Vance A
Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
Gadow KD; Nolan EE; Sverd J; Sprafkin J; Schneider J
J Child Neurol; 2008 Sep; 23(9):981-90. PubMed ID: 18474932
[TBL] [Abstract][Full Text] [Related]
6. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
8. Symptoms of attention deficit hyperactivity disorder in children are associated with cortisol responses to psychosocial stress but not with daily cortisol levels.
Pesonen AK; Kajantie E; Jones A; Pyhälä R; Lahti J; Heinonen K; Eriksson JG; Strandberg TE; Räikkönen K
J Psychiatr Res; 2011 Nov; 45(11):1471-6. PubMed ID: 21802096
[TBL] [Abstract][Full Text] [Related]
9. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
Kiliç BG; Sener S
Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
[TBL] [Abstract][Full Text] [Related]
10. Dysthymic disorder contributes to oppositional defiant behaviour in children with Attention Deficit Hyperactivity Disorder, combined type (ADHD-CT).
Vance A; Sanders M; Arduca Y
J Affect Disord; 2005 Jun; 86(2-3):329-33. PubMed ID: 15935256
[TBL] [Abstract][Full Text] [Related]
11. Physiological and psychological stress responses in adults with attention-deficit/hyperactivity disorder (ADHD).
Lackschewitz H; Hüther G; Kröner-Herwig B
Psychoneuroendocrinology; 2008 Jun; 33(5):612-24. PubMed ID: 18329819
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
[TBL] [Abstract][Full Text] [Related]
14. Effect of anxiety on cognition, behavior, and stimulant response in ADHD.
Pliszka SR
J Am Acad Child Adolesc Psychiatry; 1989 Nov; 28(6):882-7. PubMed ID: 2808258
[TBL] [Abstract][Full Text] [Related]
15. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.
Thiruchelvam D; Charach A; Schachar RJ
J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692
[TBL] [Abstract][Full Text] [Related]
16. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
Pliszka SR
Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655
[TBL] [Abstract][Full Text] [Related]
17. [Function of the hypothalamus-pituitary-adrenal axis in children with attention deficit hyperactivity disorder].
Chen YH; Chen H; Liu YY; Lin GX; Wei LX; Chen DL
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):992-5. PubMed ID: 20113607
[TBL] [Abstract][Full Text] [Related]
18. Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups.
Luby JL; Heffelfinger A; Mrakotsky C; Brown K; Hessler M; Spitznagel E
Arch Gen Psychiatry; 2003 Dec; 60(12):1248-55. PubMed ID: 14662557
[TBL] [Abstract][Full Text] [Related]
19. Autonomic correlates of attention-deficit/hyperactivity disorder and oppositional defiant disorder in preschool children.
Crowell SE; Beauchaine TP; Gatzke-Kopp L; Sylvers P; Mead H; Chipman-Chacon J
J Abnorm Psychol; 2006 Feb; 115(1):174-8. PubMed ID: 16492108
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
